ESTEVE

Company Overview

Founded in 1929 and headquartered in Barcelona, Spain, Esteve is an international pharmaceutical company with a rich Spanish legacy and an international approach around the world. The company provides both active pharmaceutical ingredients and pharmaceutical drugs. Esteve offers products in all segments, including OTC, Generics and NCEs. Esteve sales and markets its products in North America, Western Europe, Australia and the Middle East.

Esteve offers therapeutics for ophthalmology, cardiovascular, respiratory and other chronic disorders. In the field of ophthalmology, the company’s main focus is treatments for patients who suffer in eye diseases, such as glaucoma and dry eyes problems. It also offers a wide range of up-to-date and innovative treatments for the patients with chronic disease, such as hypercholesterolemia, COPD and diabetes. Esteve products include in therapeutic categories include Esomeprazole, Omeprazole Second Generation, Duloxetine HCI, Lansoprazole, Pantoprazole and Pharma Nutrition for Kids.

The company’s R&D portfolio consists of new advanced therapies for metabolic disorders and new chemical entities in the fields of analgesia and neurology. The company also offers driving-edge capacities in the manufacturing and development of complex plans, such as pellets and other strong oral structures.

Financial Highlights (FY 2024)

Company's Business Segments

• Products : Oncology, Infectiology, Neurology, Cardiovascular, Dermatology, Others
• Services : Process Development, API Manufacturing, Technologies, Others